Lilly was the only pharma bidder for Ventyx
礼来是竞购Ventyx的唯一制药公司

Eli Lilly had very little competition in its eventual deal for Ventyx Biosciences, one of the leading drug developers in the hot NLRP3 arena.
礼来在最终敲定收购Ventyx Biosciences（暂无官方中文名称）的交易时，几乎没有遇到竞争；该公司是炙手可热的NLRP3领域的领先药物开发商之一。